Article
Ozempic, Wegovy prices to drop up to 50% as Novo Nordisk’s rivalry with Eli Lilly heats up: report
Neutral
0.0
−100 Bearish
0
+100 Bullish
Drugmaker Novo Nordisk plans to slash list prices for its wildly popular weight-loss and diabetes drugs Wegovy and Ozempic by as much as 50%, according to a report.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
New York Post Business
Published
Feb 24, 2026 · 8:26 pm
Article ID
azboff4
Original URL
Open source
Sentiment Signal
Neutral
0.0
−100Neutral+100
More Like This
Newsletter